Advertisement
Singapore markets open in 15 minutes

  • Straits Times Index

    3,303.19
    +10.26 (+0.31%)
     

  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     

  • Dow

    38,852.27
    +176.59 (+0.46%)
     

  • Nasdaq

    16,349.25
    +192.92 (+1.19%)
     

  • Bitcoin USD

    63,560.02
    -640.14 (-1.00%)
     

  • CMC Crypto 200

    1,362.02
    +49.39 (+3.76%)
     

  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     

  • Gold

    2,336.10
    +4.90 (+0.21%)
     

  • Crude Oil

    78.93
    +0.45 (+0.57%)
     

  • 10-Yr Bond

    4.4890
    -0.0110 (-0.24%)
     

  • Nikkei

    38,773.36
    +537.29 (+1.41%)
     

  • Hang Seng

    18,578.30
    +102.38 (+0.55%)
     

  • FTSE Bursa Malaysia

    1,597.39
    +7.80 (+0.49%)
     

  • Jakarta Composite Index

    7,135.89
    -7,134.72 (-50.00%)
     

  • PSE Index

    6,652.49
    +36.94 (+0.56%)
     

DexCom (DXCM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks Equity Research
·2-min read

For the quarter ended March 2024, DexCom (DXCM) reported revenue of $921 million, up 24.2% over the same period last year. EPS came in at $0.32, compared to $0.17 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $911.2 million, representing a surprise of +1.08%. The company delivered an EPS surprise of +18.52%, with the consensus EPS estimate being $0.27.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

ADVERTISEMENT

Here is how DexCom performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- United States: $653.20 million compared to the $650.18 million average estimate based on five analysts. The reported number represents a change of +24.2% year over year.

  • Revenue- International: $267.80 million compared to the $261.24 million average estimate based on five analysts. The reported number represents a change of +24.3% year over year.

  • Revenue- Hardware: $66.70 million versus $92.54 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -25.6% change.

  • Revenue- Sensor and other: $854.30 million versus $821.02 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +31.1% change.

View all Key Company Metrics for DexCom here>>>

Shares of DexCom have returned -1.2% over the past month versus the Zacks S&P 500 composite's -3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

DexCom, Inc. (DXCM) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research